Interventions for valvular disease and heart failure

Monitoring pulmonary artery pressure in chronic heart failure patients and evaluating the treatment effect of MitraClip implantation for functional mitral regurgitation

EuroIntervention 2019;15:418-419. DOI: 10.4244/EIJ-D-18-01188

Jesse Veenis
Jesse Feiko Veenis1, MD; Nicolas M. Van Mieghem1, MD, PhD, FESC; Kadir Caliskan1, MD, PhD, FESC; Olivier C. Manintveld1, MD, PhD; Jasper J. Brugts1, MD, PhD, FESC, MSc
1. Department of Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

Figure 1. Pre- and post-MitraClip daily PAP readings.

In chronic heart failure (HF) patients, functional mitral valve regurgitation (FMR) is a common finding and is associated with worse outcome. The position of the MitraClip™ (Abbott Vascular, Santa Clara, CA, USA) as a therapeutic option is still debated after the publication of the MITRA-FR and COAPT trials, showing conflicting results.

A 51-year-old male, with a history of severely dilated, non-ischaemic cardiomyopathy, severe FMR, actively on the heart transplant (HTx) waiting list, remotely monitored with the CardioMEMS™ sensor (Abbott Vascular), developed persistent elevated pulmonary artery pressures (PAPs) (...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Interventions for valvular diseaseInterventions for heart failureMitral valve replacement and repairChronic heart failure
Read next article
Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry

Latest news